Indian in US varsity claims new path to cancer cure

Image
IANS New Delhi
Last Updated : Feb 07 2014 | 2:56 PM IST

Arnab De, an Indian scientist working at Columbia University in the US, claims to have found a new biological pathway that holds hope for cancer cure.

De also claims to have discovered a previously unknown biological pathway that is essential to fight off infections caused by bacteria and viruses. He says he has developed a transgenic animal model, an animal in which there has been a deliberate modification of the genome that could be used to study the role of A20 gene for cancer cure.

"I have created a transgenic mouse to study the action of A20 (gene) in living animals. "It will help to understand the mechanism by which A20 works in healthy individuals and patients," De, a postdoctoral scientist at Columbia University, told IANS over phone from the US.

He said that "A20 is a tumor-suppressor and this one gene is dysfunctional in a number of different cancers".

"For example, we find that patients of both B cell lymphoma and lung cancer have mutations in this gene, although at different places along the gene. We cloned stem cells having a single active amino acid mutation of A20. We then injected these bioengineered stem cells into blastocysts and subsequently generated transgenic knock-in animals from these stem cells.

"Previous understanding of A20 would have predicted the development of the various diseases in these animals. Surprisingly, these animals developed normally and had a healthy life. It is obvious to see why the work has important ramifications for cancer patients," said De.

He was involved in the two high-profile projects and has worked with internationally reputed Indian-American immunologist Sankar Ghosh.

De, who completed his PhD from Columbia University, is a cricket aficionado and has chosen to dedicate his thesis to Indian batting legend Sachin Tendulkar.

"Sachin Tendulkar is the greatest batsman of the post-war era and holds every record that we can imagine. I dedicate this thesis to Tendulkar for the way he has inspired Indian youth for the past 25 years."

Arnab has also helped in a drug-discovery at Indiana University where he worked with Richard DiMarchi, a professor.

(Jitendra Singh can be contacted at scribejks@gmail.com)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 07 2014 | 2:54 PM IST

Next Story